About | HeinOnline Law Journal Library | HeinOnline Law Journal Library | HeinOnline
LOG IN
LOG IN

Explanation of Estimate of S. 812 [i] (September 2002)

handle is hein.congrec/cbo9247 and id is 1 raw text is: Explanation of Estimate of S. 812 CBO estimates approximately $4.7 trillion in total prescription drug expenditures in the U.S. over the ten-year period (2003 through 2012). Approximately $320 billion (around 7 percent) of total expenditures could be saved over the ten-year period if all delays in the market entry of generics related to patent challenges were eliminated. This legislation would reduce the delay by about 20 percent, thus reducing total drug spending by about $60 billion (or 1.3 percent) across the country over the next ten years. Because the proportion of pharmaceuticals purchased or provided by the federal government is quite low, reducing the delay in the entry of generics would reduce federal direct spending for prescription drugs by $5.9 billion and increase federal revenues by $2.2 billion. (The revenue effect occurs, because with lower drug costs, a greater proportion of employees' compensation would be in the form of taxable income.)

What Is HeinOnline?

HeinOnline is a subscription-based resource containing thousands of academic and legal journals from inception; complete coverage of government documents such as U.S. Statutes at Large, U.S. Code, Federal Register, Code of Federal Regulations, U.S. Reports, and much more. Documents are image-based, fully searchable PDFs with the authority of print combined with the accessibility of a user-friendly and powerful database. For more information, request a quote or trial for your organization below.



Short-term subscription options include 24 hours, 48 hours, or 1 week to HeinOnline.

Purchase Access

Contact us for annual subscription options:

Contact Us

Already a HeinOnline Subscriber?

Log In

profiles profiles most